Literature DB >> 1900084

Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells.

J O Hill1, A G Harmsen.   

Abstract

The contribution of T lymphocyte subpopulations to intrapulmonary and systemic resistance against an opportunistic strain of Cryptococcus neoformans was examined. It was found that C. neoformans was destroyed when introduced into the lungs of normal mice, but disseminated to the brains of mice treated with an antibody that depleted them of CD4+ T cells. Depletion of either CD8+ or CD4+ T cells impaired the ability of the host to clear the yeast from the lung. These results, together with the observation that CD8+ T cells accumulate in the lungs of CD4+ T cell-deficient mice, suggest that CD8+ T cells play an important role in resistance to C. neoformans infection acquired via the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900084      PMCID: PMC2118808          DOI: 10.1084/jem.173.3.755

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.

Authors:  N L Gutstein; D Wofsy
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

2.  Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.

Authors:  R L Tarleton
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

3.  T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity.

Authors:  M E Mielke; S Ehlers; H Hahn
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

4.  Cryptococcosis in the acquired immunodeficiency syndrome.

Authors:  J A Kovacs; A A Kovacs; M Polis; W C Wright; V J Gill; C U Tuazon; E P Gelmann; H C Lane; R Longfield; G Overturf
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

5.  In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects.

Authors:  G P Miller; J Puck
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

6.  Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

Authors:  A Zuger; E Louie; R S Holzman; M S Simberkoff; J J Rahal
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

7.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

8.  Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes.

Authors:  S L Hoffman; D Isenbarger; G W Long; M Sedegah; A Szarfman; L Waters; M R Hollingdale; P H van der Meide; D S Finbloom; W R Ballou
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

9.  Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.

Authors:  J O Hill; M Awwad; R J North
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans.

Authors:  C H Mody; M F Lipscomb; N E Street; G B Toews
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

View more
  57 in total

1.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Pulmonary cryptococcosis.

Authors:  G B Huffnagle; M F Lipscomb
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

3.  Requirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice.

Authors:  K L Buchanan; H A Doyle
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Jatin M Vyas; Stuart M Levitz
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.

Authors:  Karen L Wozniak; Camaron R Hole; Junko Yano; Paul L Fidel; Floyd L Wormley
Journal:  Microbiology (Reading)       Date:  2014-04-23       Impact factor: 2.777

6.  Effect of cytokines on anticryptococcal activity of human microglial cells.

Authors:  M M Lipovsky; A E Juliana; G Gekker; S Hu; A I Hoepelman; P K Peterson
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

7.  Decreased resistance to primary intravenous Cryptococcus neoformans infection in aged mice despite adequate resistance to intravenous rechallenge.

Authors:  K M Aguirre; G W Gibson; L L Johnson
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Authors:  S M Levitz; M P Dupont
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells.

Authors:  E Blasi; R Mazzolla; R Barluzzi; P Mosci; F Bistoni
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas.

Authors:  D Goldman; Y Cho; M Zhao; A Casadevall; S C Lee
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.